French Parkinson's Disease Cohort - NS-PARK
ConditionParkinson Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age10+
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
About this trial
The aim of NS-PARK cohort are to describe the natural history of Parkinson's disease (PD), and to propose patients stratification models based on PD pathophysiological mechanisms. Patients are included at all PD expert centers in France. Standardized demographic, diagnosis, motor and non-motor symptoms evaluation, and treatment information are collected, and clinical data are updated at each visit of the patient at the center. A blood sampling is perform at baseline for genetic testing and implement an associated biocollection.
Eligibility criteria
Qualifiers
Diagnosis of Parkinson's disease according to UK PD brain bak criteria
OR diagnosis of parkinsonian syndrome: multiple system atrophy, progressive supranuclear palsy, dementia with Lewy body, or corticobasal syndrom
Affiliated to social security
Age > 10 years
Disqualifiers
Subject under legal protection
Subject who do not consent to the research
for the optional skin biopsy only: clinically significant coagulation abnormalities or anticoagulant treatment
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov